Impact of Molybdenum Compounds as Anticancer Agents

The aim of this mini review was to report the molybdenum compound intervention to control cancer disease. The intervention explains its roles and progress from inorganic molybdenum compounds via organomolybdenum complexes to its nanoparticles to control oesophageal cancer and breast cancer as case s...

Descripción completa

Detalles Bibliográficos
Autores principales: Odularu, Ayodele T., Ajibade, Peter A., Mbese, Johannes Z.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6754869/
https://www.ncbi.nlm.nih.gov/pubmed/31582964
http://dx.doi.org/10.1155/2019/6416198
_version_ 1783453128151007232
author Odularu, Ayodele T.
Ajibade, Peter A.
Mbese, Johannes Z.
author_facet Odularu, Ayodele T.
Ajibade, Peter A.
Mbese, Johannes Z.
author_sort Odularu, Ayodele T.
collection PubMed
description The aim of this mini review was to report the molybdenum compound intervention to control cancer disease. The intervention explains its roles and progress from inorganic molybdenum compounds via organomolybdenum complexes to its nanoparticles to control oesophageal cancer and breast cancer as case studies. Main contributions of molybdenum compounds as anticancer agents could be observed in their nanofibrous support with suitable physicochemical properties, combination therapy, and biosensors (biomarkers). Recent areas in anticancer drug design, which entail the uses of selected targets, were also surveyed and proposed.
format Online
Article
Text
id pubmed-6754869
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-67548692019-10-03 Impact of Molybdenum Compounds as Anticancer Agents Odularu, Ayodele T. Ajibade, Peter A. Mbese, Johannes Z. Bioinorg Chem Appl Review Article The aim of this mini review was to report the molybdenum compound intervention to control cancer disease. The intervention explains its roles and progress from inorganic molybdenum compounds via organomolybdenum complexes to its nanoparticles to control oesophageal cancer and breast cancer as case studies. Main contributions of molybdenum compounds as anticancer agents could be observed in their nanofibrous support with suitable physicochemical properties, combination therapy, and biosensors (biomarkers). Recent areas in anticancer drug design, which entail the uses of selected targets, were also surveyed and proposed. Hindawi 2019-09-10 /pmc/articles/PMC6754869/ /pubmed/31582964 http://dx.doi.org/10.1155/2019/6416198 Text en Copyright © 2019 Ayodele T. Odularu et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Odularu, Ayodele T.
Ajibade, Peter A.
Mbese, Johannes Z.
Impact of Molybdenum Compounds as Anticancer Agents
title Impact of Molybdenum Compounds as Anticancer Agents
title_full Impact of Molybdenum Compounds as Anticancer Agents
title_fullStr Impact of Molybdenum Compounds as Anticancer Agents
title_full_unstemmed Impact of Molybdenum Compounds as Anticancer Agents
title_short Impact of Molybdenum Compounds as Anticancer Agents
title_sort impact of molybdenum compounds as anticancer agents
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6754869/
https://www.ncbi.nlm.nih.gov/pubmed/31582964
http://dx.doi.org/10.1155/2019/6416198
work_keys_str_mv AT odularuayodelet impactofmolybdenumcompoundsasanticanceragents
AT ajibadepetera impactofmolybdenumcompoundsasanticanceragents
AT mbesejohannesz impactofmolybdenumcompoundsasanticanceragents

Ejemplares similares